Quest Historical Income Statement
| DGX Stock | USD 163.59 0.30 0.18% |
Historical analysis of Quest Diagnostics income statement accounts such as Selling General Administrative of 1.5 B or Total Revenue of 6.9 B can show how well Quest Diagnostics Incorporated performed in making a profits. Evaluating Quest Diagnostics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Quest Diagnostics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Quest Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Quest Diagnostics is a good buy for the upcoming year.
Quest |
About Quest Income Statement Analysis
Quest Diagnostics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Quest Diagnostics shareholders. The income statement also shows Quest investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Quest Diagnostics Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Quest Diagnostics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Quest Diagnostics Incorporated minus its cost of goods sold. It is profit before Quest Diagnostics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Quest Diagnostics. It is also known as Quest Diagnostics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Quest Diagnostics financial statement analysis. It represents the amount of money remaining after all of Quest Diagnostics Incorporated operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Quest Diagnostics Incorporated whose combined shares represent less than 50% of the total outstanding shares issued by Quest Diagnostics have a minority interest in Quest Diagnostics.Most accounts from Quest Diagnostics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Quest Diagnostics' EBITDA is fairly stable compared to the past year. Selling And Marketing Expenses is likely to rise to about 18.8 K in 2024, whereas Depreciation And Amortization is likely to drop slightly above 265.1 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 4.2B | 3.4B | 3.1B | 2.7B | Total Revenue | 10.8B | 9.9B | 9.3B | 6.9B |
Quest Diagnostics income statement Correlations
Click cells to compare fundamentals
Quest Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Quest Diagnostics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 349M | 361M | 408M | 437M | 439M | 265.1M | |
| Interest Expense | 167M | 175M | 163M | 138M | 152M | 99.3M | |
| Selling General Administrative | 1.5B | 1.6B | 1.7B | 1.8B | 1.8B | 1.5B | |
| Total Revenue | 7.7B | 9.4B | 10.8B | 9.9B | 9.3B | 6.9B | |
| Gross Profit | 2.7B | 3.6B | 4.2B | 3.4B | 3.1B | 2.7B | |
| Other Operating Expenses | 6.5B | 7.5B | 8.4B | 8.5B | 8.0B | 5.8B | |
| Operating Income | 1.2B | 2.0B | 2.4B | 1.4B | 1.3B | 1.1B | |
| Ebit | 1.2B | 2.1B | 2.8B | 1.4B | 1.3B | 1.1B | |
| Ebitda | 1.6B | 2.4B | 3.2B | 1.8B | 1.3B | 1.3B | |
| Cost Of Revenue | 5.0B | 5.8B | 6.6B | 6.5B | 6.2B | 4.2B | |
| Total Operating Expenses | 1.5B | 1.7B | 1.8B | 2.0B | 1.6B | 1.6B | |
| Income Before Tax | 1.1B | 1.9B | 2.6B | 1.2B | 1.1B | 962.5M | |
| Total Other Income Expense Net | (155M) | (87M) | 218M | (193M) | (132M) | (125.4M) | |
| Net Income | 858M | 1.4B | 2.0B | 946M | 854M | 619.9M | |
| Income Tax Expense | 247M | 460M | 597M | 264M | (248M) | (235.6M) | |
| Net Income Applicable To Common Shares | 858M | 1.4B | 2.0B | 942M | 1.1B | 758.9M | |
| Minority Interest | 48M | 68M | (85M) | (69M) | (56M) | (53.2M) | |
| Net Income From Continuing Ops | 886M | 1.5B | 2.1B | 1.0B | 819M | 983.8M | |
| Non Operating Income Net Other | 77M | 151M | 447M | (11M) | (12.7M) | (12.0M) | |
| Tax Provision | 247M | 460M | 597M | 264M | 204M | 266.4M | |
| Interest Income | 5M | 163M | 151M | 138M | 9M | 8.6M | |
| Net Interest Income | (167M) | (175M) | (163M) | (138M) | (144M) | (151.2M) | |
| Reconciled Depreciation | 329M | 361M | 408M | 437M | 446M | 402.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.